Response Biomedical Announces Strategic Alliance with 3M To Commercialize Rapid Infectious Disease Tests Thursday December 7, 7:26 pm ET Initial Product Launch Expected in 2007 3M Makes Equity Investment in Response Biomedical
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.